Speakers

Patricia Kelly
Singer, Songwriter, Keynote Speaker, Bestselling Author, Entrepreneur, Member of the Kelly Family

Dr Rainer Gnibl, Government of Upper Bavaria, Germany
Head of Inspectorate and GMP Inspector, Advisory Board member of EQPA

Alexander Kammerlocher, District Government, Germany
Inspector for Medical and Pharmaceutical Affairs, Medical Devices

Mag.pharm. Andreas Kraßnigg, Austrian Agency for Health and Food Safety (AGES), Austria
Head Pharmaceutical Inspections and member of Annex 16 Drafting Group, Chair of the PIC/S Sub-Committee on Expert Circles and Advisory Board member of EQPA

Richard O’Sullivan, HPRA, Ireland
GMP Inspector at Irish Health Products Regulatory Authority (HPRA)

Martine Powell, MHRA, UK
Expert GMP Inspector, Healthcare Quality and Access Group, Medicines and Healthcare Products Regulatory Agency

other GMP Inspectors invited

Cheryl Chia, BeiGene, The Netherlands
Senior Director Distribution Quality, member of the EQPA Board of Directors

David Cockburn, EQPA and ECA, UK
Member of the EQPA Board of Directors and the ECA Executive Board. Former Chair of the EMA GMP/GDP IWG

Dr Susanne Ding, Boehringer Ingelheim, Germany
Qualified Person for IMPs, member of the EQPA Board of Directors

Eike Feldmann, Sharp Services, The Netherlands
Qualified Person Market Release and independent consultant

Georg Göstl, Takeda, Austria
Qualified Person, Chair of the Austrian QP Association aqpa, member of the EQPA Board of Directors

Rebecca Haywood, Pfizer, UK
Qualified Person

Cecilie Hejlskov, Syntese, Denmark
Operational Excellence Manager

Dr Arnoud Herremans, Y47 Consultancy, The Netherlands
Owner and Lean Kaizen Consultant

Katrien Himpens, J&J Innovative Medicine, Belgium
Qualified Person IMP, Senior Director QA Clinical Supply Chain

Dr Monika Hupfauf, Attorney-at Law, Austria
Lawyer with focus on the development of pharmaceuticals and medical products up to and including market entry

Patryk Jegorow, Takeda, Ireland
Qualified Person and Head of Quality Compliance and Systems Biologics Operating Unit

Dr Ulrich Kissel, EQPA, Germany
Qualified Person and Chairman of the EQPA Board of Directors

Dr Nina Langoth-Fehringer, Langoth Pharma Consulting, Austria
Consultant

Aidan Madden, FivePharma, Ireland
CEO

Sue Mann, Sue Mann Consultancy Ltd., UK
Qualified Person and QP Assessor working on behalf of the MHRA, representing the Royal Pharmaceutical Society

Dr Umberto M. Musazzi, University of Milan, Italy
Fixed-term Research Fellow B, Department of Pharmaceutical Sciences

Paul Palmer, Pharma Quality Services Limited, UK
Managing Director, QP, RP and RPi, Honorary Senior Lecturer University College London

Martin Quigley, Quigley and Associates, Ireland
Enneagram specialist, trainer, coach and author of the book “More than a Number”

Gillian Renouf, Royal Pharmaceutical Society QP Assessment Panel, UK
Chair of the RPS QP Assessment Panel, Country Quality Head UK, Ireland and Nordics at Novartis

Mounir Rizovsky, Clinigen, Belgium
Lead Qualified Person, Clinical Supplies Management

Markus Roemer, comes compliance services, Germany
Managing Director

Ewa Rybak, JJP Biologics, Poland
Qualified Person and Head of Quality Compliance and Quality Systems, member of the EQPA Board of Directors

Charis Schmidt, Ferring, Germany
Head of Production/ Team Lead Sterile Production

Dr Andreas Schwinn, Roche Pharma AG, Germany
Senior Qualified Person

Aleksandra Szymczak, Delpharm Poznań, Poland
Qualified Person, Controlled Substances Supervisor